Dissemination Approaches for Different Audiences
Section 8
Additional Resources
| Resource | Description |
| Communications tool kits | |
| Health Foundation
|
Guide to assist health researchers in developing a communication strategy. Considerations include context, key messaging and objectives, audience, communications channels, and additional resources |
| Vanderbilt Dissemination Toolkit
|
Collection of dissemination tool kits that are free for download and use. The tool kits contain guidelines, strategies, checklists, worksheets, templates, examples, and case studies for developing dissemination plans and products. |
| PCORI Dissemination and Implementation Framework and Toolkit
|
Framework was developed by Mathematica, AcademyHealth, and Palladian Partners to provide information and tools for designing and implementing a robust dissemination strategy informed by multiple stakeholder groups |
| Canadian Institutes of Health Research (CIHR): Knowledge Translation
|
Resources for knowledge translation, a dynamic and iterative process that includes “synthesis, dissemination, exchange, and ethically-sound application of knowledge to improve health” |
| Information on Finding Reputable Journals | |
|
|
| Authorship and conflict of interest | |
| International Committee of Medical Journal Editors (ICJME) recommendations | Criteria for authorship for peer-reviewed journals and author responsibilities for reporting conflicts of interest |
| Reporting and dissemination tools | |
| PCORI Dissemination and Implementation Framework and Toolkit | Resource for facilitating strategic planning for sharing information and putting new evidence into practice to speed change. |
| Aggregate Analysis of ClinicalTrial.gov (AACT) | CTTI created the AACT database, a publicly accessible ClinicalTrials.gov dataset that can be used to analyze studies and characterize the current state of clinical trials, including at the individual specialty level. |
SECTIONS
CHAPTER SECTIONS
ACKNOWLEDGMENTS
Karen Staman, Gina Uhlenbrauck, and Liz Wing of the NIH Pragmatic Trials Collaboratory Coordinating Center served as contributing editors for previous versions of this chapter.